A general view shows the Merck facility in Rahway, New Jersey November 28, 2005. Pharmaceutical company Merck and Co. Inc. on Monday said it agreed to acquire biotechnology firm Sirna Therapeutics Inc. for $1.1 billion in cash to bolster its research and development efforts in areas such as cancer treatments. (Jeff Zelevansky/Reuters)
